What is GALT stock price today?

Visit our real-time dashboard for the current GALT stock price and live market data.

Is GALT stock going up or down today?

GALT stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GALT stock now?

The decision to buy GALT depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GALT a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GALT based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GALT stock overvalued or undervalued?

Use our DCF valuation calculator to determine if GALT is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is GALT's P/E ratio?

P/E ratio data for GALT will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is GALT's market cap?

GALT (Galectin Therapeutics Inc) has a market capitalization of $0.14 billion, making it a small-cap stock.

What is GALT's price to book ratio?

Price-to-book ratio for GALT is available on our dashboard along with other valuation metrics.

Does GALT pay dividends?

GALT does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is GALT's dividend yield?

GALT does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is GALT stock a good long-term investment?

GALT's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GALT's revenue growth rate?

Revenue growth data for GALT is available on our dashboard with detailed financial statement analysis.

Profitability metrics for GALT are available on our dashboard with complete income statement analysis.

What are the risks of investing in GALT?

Key risks for GALT include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GALT compare to its competitors?

Compare GALT to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GALT's performance and positioning.

What is GALT's stock price target for 2026?

Visit our prediction page for AI-powered price targets for GALT with bull, base, and bear case scenarios.

What do analysts say about GALT?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GALT. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GALT's next earnings report?

GALT reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GALT - Galectin Therapeutics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Galectin Therapeutics Inc

Galectin Therapeutics Inc (GALT) common stock

Price Chart

Loading chart...

GALT Key Statistics

Market Cap

$142.41M

How GALT Compares to Peers

GALT is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GALT(This stock)	$142.41M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 16, 2026 at 4:23 AM EDT

Ready to invest in GALT?

Commission-free trading available. Affiliate links.

GALT Lician Score

5% confidence

4.0/10

Neutral

GALT has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates GALTacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

GALT Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for GALT

Dashboard

Enter a ticker to analyze